Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Completed 2Active not recruiting 2Withdrawn 1Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Stage IB Cervical Cancer FIGO 2018 1Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Pancreatic Cyst 1Ovarian Neoplasms 1Hematologic Neoplasms 1Genital Neoplasms, Female 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Cancer Survivor 1Anxiety Disorders 1

Interventions

Gemcitabine 27Taxes 9Capecitabine 8Albumin-Bound Paclitaxel 6pembrolizumab 5Radiosurgery 5Oxaliplatin 5Bevacizumab 5130-nm albumin-bound paclitaxel 5Surgical Procedures, Operative 4Specimen Handling 4Secretin 4Fluorouracil 4Drug Therapy 4Ascorbic Acid 4durvalumab 3Magnetic Resonance Spectroscopy 3Leucovorin 3Irinotecan 3Cyclophosphamide 3Cisplatin 3Biopsy 3palbociclib 2methylnaltrexone 2folfirinox 2fludarabine 2entinostat 2aldesleukin 2Trastuzumab 2Standard of Care 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Pancreatic Neoplasms × Methods × Clear all
NCT01927393 2014-12-23

Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer

City of Hope Medical Center

Phase NA Withdrawn
GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡